Arthneeti
All Q2 FY27 results →
YC

Yasons Chemex Care Ltd

Q2 FY27Chemicals & Petrochemicals

Yasons Chemex Care Q2 Results 2026 (FY27) statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Price₹8
Market cap₹14 Cr
P/E15.4
Updated31 Oct 2026
Read3 min read

Based on Yasons Chemex Care Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

The short version

Revenue from operations for the half year ended September 30, 2026, was Rs. Quarterly EBITDA: ₹549 Crore, up 16% YoY - Quarterly Operating Margin: 18.1%, up 160 bps YoY - Quarterly Profit After Tax (PAT): ₹382 Crore, up 7% YoY - Explicit Margin Outlook: Th

From Yasons Chemex Care Ltd's Q2 FY27 earnings-call transcript · updated 31 Oct 2026.

Revenue & Sales Performance

- Revenue from operations for the half year ended September 30, 2026, was Rs. 4,121.58 lakhs (consolidated), compared to Rs. 4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). - Standalone revenue from operations was Rs. 2,725.99 lakhs for the half year ended September 30, 2026, down from Rs. 3,604.69 lakhs for the half year ended September 30, 2025, a year-on-year decrease of approximately 24.4% (Page 4). Summary: The document reports a decline in revenue year-on-year.

Profitability & Margins

See what Yasons Chemex Care Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The presentation mentions the following capital expenditure (capex) and expansion details: - **Issue related expenses**: INR 339.37 Lakhs fully utilized. - **Working capital requirements**: INR 1,230.63 Lakhs fully utilized.

2 more points from Yasons Chemex Care Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries Ltd
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Yasons Chemex Care Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Yasons Chemex Care Ltd said on order book & pipeline — free account, 30 seconds.

Continue your research

Others in Chemicals & Petrochemicals this season

  • Neogen Chemicals Ltd (Q2 FY27)

    Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how

  • Mahickra Chemicals Ltd (Q2 FY27)

    682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Vishnu Chemicals Ltd (Q2 FY27)

    2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec

  • Poddar Pigments Ltd (Q2 FY27)

    450.67 lakh (~4.9%). Key results statement takeaways from Poddar Pigments Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

Compare:vs Solar Industriesvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Yasons Chemex Care Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Yasons Chemex Care Ltd Q2 FY27 results?

Revenue from operations for the half year ended September 30, 2026, was Rs. Quarterly EBITDA: ₹549 Crore, up 16% YoY - Quarterly Operating Margin: 18.1%, up 160 bps YoY - Quarterly Profit After Tax (PAT): ₹382 Crore, up 7% YoY - Explicit Margin Outlook: Th

What is Yasons Chemex Care Ltd share price analysis?

Yasons Chemex Care Ltd currently shows a neutral. The stock trades at a P/E of 15.4 with a market cap of ₹14 Cr. Investors should review the full earnings analysis for detailed insights.

Is Yasons Chemex Care Ltd planning capital expenditure?

The presentation mentions the following capital expenditure (capex) and expansion details: - Issue related expenses: INR 339.37 Lakhs fully utilized. - Working capital requirements: INR 1,230.63 Lakhs fully utilized. - General corporate purpose: INR 486.80 Lakhs; utilized INR 486.48 Lakhs with INR 0.32 Lakhs unutilized as of the report date. - Investments in Property, Plant and Equipment (PPE) increased from Rs.

Keep Yasons Chemex Care Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.